Ashfield Capital Partners’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $626K | Hold |
5,104
| – | – | 0.05% | 161 |
|
|
2022
Q2 | $679K | Hold |
5,104
| – | – | 0.05% | 156 |
|
|
2022
Q1 | $699K | Sell |
5,104
-693
| -12% | -$96.6K | 0.05% | 172 |
|
|
2021
Q4 | $1M | Hold |
5,797
| – | – | 0.06% | 152 |
|
|
2021
Q3 | $842K | Hold |
5,797
| – | – | 0.06% | 159 |
|
|
2021
Q2 | $765K | Sell |
5,797
-1
| -0% | -$131 | 0.05% | 169 |
|
|
2021
Q1 | $744K | Hold |
5,798
| – | – | 0.06% | 166 |
|
|
2020
Q4 | $691K | Hold |
5,798
| – | – | 0.06% | 164 |
|
|
2020
Q3 | $664K | Hold |
5,798
| – | – | 0.06% | 157 |
|
|
2020
Q2 | $661K | Hold |
5,798
| – | – | 0.07% | 153 |
|
|
2020
Q1 | $466K | Sell |
5,798
-50
| -0.9% | -$5.18K | 0.06% | 166 |
|
|
2019
Q4 | $625K | Hold |
5,848
| – | – | 0.06% | 165 |
|
|
2019
Q3 | $626K | Sell |
5,848
-223
| -4% | -$22.9K | 0.07% | 160 |
|
|
2019
Q2 | $618K | Hold |
6,071
| – | – | 0.07% | 166 |
|
|
2019
Q1 | $546K | Hold |
6,071
| – | – | 0.06% | 177 |
|
|
2018
Q4 | $506K | Hold |
6,071
| – | – | 0.07% | 175 |
|
|
2018
Q3 | $655K | Sell |
6,071
-442
| -7% | -$48.5K | 0.07% | 167 |
|
|
2018
Q2 | $716K | Hold |
6,513
| – | – | 0.09% | 163 |
|
|
2018
Q1 | $653K | Hold |
6,513
| – | – | 0.09% | 175 |
|
|
2017
Q4 | $641K | Sell |
6,513
-1,227
| -16% | -$116K | 0.08% | 175 |
|
|
2017
Q3 | $725K | Sell |
7,740
-20
| -0.3% | -$2.12K | 0.1% | 160 |
|
|
2017
Q2 | $863K | Hold |
7,760
| – | – | 0.12% | 156 |
|
|
2017
Q1 | $762K | Sell |
7,760
-1,059
| -12% | -$101K | 0.11% | 165 |
|
|
2016
Q4 | $810K | Sell |
8,819
-3,401
| -28% | -$293K | 0.08% | 154 |
|
|
2016
Q3 | $1.03M | Hold |
12,220
| – | – | 0.09% | 147 |
|
|
2016
Q2 | $995K | Hold |
12,220
| – | – | 0.08% | 145 |
|
|
2016
Q1 | $873K | Hold |
12,220
| – | – | 0.06% | 155 |
|
|
2015
Q4 | $869K | Hold |
12,220
| – | – | 0.06% | 163 |
|
|
2015
Q3 | $751K | Hold |
12,220
| – | – | 0.05% | 176 |
|
|
2015
Q2 | $886K | Sell |
12,220
-400
| -3% | -$29.5K | 0.05% | 175 |
|
|
2015
Q1 | $970K | Hold |
12,620
| – | – | 0.05% | 168 |
|
|
2014
Q4 | $846K | Hold |
12,620
| – | – | 0.04% | 178 |
|
|
2014
Q3 | $766K | Sell |
12,620
-654
| -5% | -$40.3K | 0.04% | 186 |
|
|
2014
Q2 | $779K | Sell |
13,274
-6,947
| -34% | -$407K | 0.04% | 182 |
|
|
2014
Q1 | $1.17M | Sell |
20,221
-1,714
| -8% | -$91.9K | 0.06% | 145 |
|
|
2013
Q4 | $1.17M | Sell |
21,935
-680
| -3% | -$40.3K | 0.06% | 143 |
|
|
2013
Q3 | $1.4M | Sell |
22,615
-350
| -2% | -$20.9K | 0.07% | 126 |
|
|
2013
Q2 | $1.39M | Buy |
+22,965
| New | +$1.37M | 0.08% | 124 |
|
Other funds holding DGX
Ashfield Capital Partners's DGX Position: Q3 2022 in Review
Ashfield Capital Partners held its Quest Diagnostics (DGX) position steady in Q3 2022 at 5,104 shares worth $626K. The position accounts for 0.05% of the portfolio, ranked #161.
Ashfield Capital Partners first reported a position in DGX in Q2 2013 and has held it in 38 quarters since. The position peaked at $1.4M in Q3 2013. 808 funds tracked by Wall St. Rank hold DGX as of Q3 2022.
- Ashfield Capital Partners held 5,104 shares of Quest Diagnostics worth $626K as of Q3 2022.
- Ashfield Capital Partners left its Quest Diagnostics share count unchanged in Q3 2022.
- Quest Diagnostics made up 0.05% of Ashfield Capital Partners's portfolio in Q3 2022, its #161 holding.
- Ashfield Capital Partners first reported a position in Quest Diagnostics in Q2 2013 and has held it in 38 quarters since.
- Ashfield Capital Partners's Quest Diagnostics position peaked at $1.4M in Q3 2013.
- 808 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2022.
Based on Ashfield Capital Partners's 13F filing for Q3 2022, filed 10 Nov 2022.